Placental membrane preparation and methods of making and using same
View Patent ↗This disclosure relates to placental membrane preparations and the methods of preparing and using thereof. In some embodiments, the disclosure relates to a placental membrane preparation. In some embodiments, the disclosure relates to methods of producing a placental membrane preparation. In some embodiments, the disclosure relates to methods of treating cartilage using placental membrane preparations.
1. A method of generating cartilage in vivo in a skeletal joint comprising:
removing diseased cartilage from the skeletal joint thereby forming a void and exposing a subchondral bone, implanting a placental membrane preparation into the void of the skeletal joint wherein the placental membrane preparation comprises an intact placental membrane sheet and a demineralized bone powder (DBP) applied thereto, and generating chondrocytes within the void of the skeletal joint via differentiation of viable mesenchymal stem cells that are native to and have not been isolated from the intact placental membrane sheet without differentiation of the mesenchymal stem cells into osteoblasts.
2. The method according to claim 1 wherein the intact placental membrane sheet excludes a chorion.
3. The method according to claim 1 further comprising directly contacting an epithelial cell layer of an amnion side of the intact placental membrane sheet to the skeletal joint.
4. The method according to claim 1 further comprising directly contacting an epithelial cell layer of an amnion side of the intact placental membrane sheet to the skeletal joint without directly contacting a chorion side of the intact placental membrane sheet to the skeletal joint.
5. The method according to claim 1 wherein the preparation is essentially free of chondrocytes when implanted into the skeletal joint.
6. The method according to claim 1 further comprising implanting the preparation into the skeletal joint no more than 6 hours after the DBP is applied to the placental membrane sheet.
7. The method according to claim 1 further comprising generating chondrocytes within the intact placental membrane sheet via differentiation of the mesenchymal stem cells that are native to the intact placental membrane sheet and in the absence of growth factors derived from sources other than the intact placental membrane sheet and the DBP.
8. The method according to claim 1 further comprising generating hyaline articular cartilage within the skeletal joint from the preparation via differentiation of the mesenchymal stem cells that are native to the intact placental membrane sheet with no fibrocartilage generation.
9. The method according to claim 1 wherein, prior to implantation, the intact placental membrane sheet is arranged in a manner so that only an epithelial layer of cells of the intact placental membrane sheet directly contacts the skeletal joint when implanted therein.
10. The method according to claim 1 wherein the placental membrane preparation includes a plurality of stacked placental membrane sheets, wherein the placental membrane sheets of the plurality of stacked placental membrane sheets are separate sheets.
11. A method of generating cartilage in vivo in a skeletal joint comprising, removing a diseased cartilage portion from a cartilage body of the skeletal joint thereby forming a void, providing an implant that includes a placental membrane sheet having an epithelial monolayer and viable mesenchymal stem cells that are native to the placental membrane sheet, the mesenchymal stem cells being separated from the epithelial monolayer by a basement membrane of the placental membrane sheet, arranging the implant to present with an exterior surface portion having an upper surface displaying the epithelial monolayer and a lower surface portion displaying the epithelial monolayer, placing the implant into the void, wherein the void is defined by a sidewall, a bottom, and an upper opening, and reducing differentiation of the mesenchymal stem cells into osteoblasts by arranging the implant within the void so that the lower surface portion contacts the bottom and the upper surface portion faces the upper opening.
12. The method according to claim 11 wherein bleeding is minimized during the removal of the diseased cartilage.
13. The method according to claim 11 wherein bleeding is minimized in part by the application of a hemostatic agent.
14. The method according to claim 11 wherein the bleeding is minimized in part by the avoidance of abrasions to the subchondral bone and calcified cartilage.
15. The method according to claim 11 wherein the removal of healthy cartilage is minimized during the removal of the diseased cartilage.
16. The method according to claim 11 wherein the placental membrane sheet includes a chorion layer impregnated with demineralized bone powder.
17. The method according to claim 16 wherein the chorion layer of the placental membrane sheet includes a viable stromal cell layer.
18. The method according to claim 11 wherein the placental membrane sheet includes a demineralized bone powder.
19. The method according to claim 14 wherein the implant is essentially free of chondrocytes at the moment when placed into the void.
20. The method according to claim 14 wherein the implant is free of osteoblasts at the moment when placed into the void.
21. The method according to claim 14 wherein the implant is free of osteoblasts six months after placement into the void.
22. The method according to claim 14 wherein a majority of the mesenchymal stem cells differentiate into hyaline cartilage cells following placement of the implant into the void.
23. A method of generating cartilage in vivo in a skeletal joint comprising:
inserting a demineralized bone powder-impregnated first intact placental membrane sheet into a void formed in a cartilage body of a skeletal joint, the void containing bone marrow, and generating chondrocytes within the cartilage body via differentiation of viable mesenchymal stem cells that are native to and have not been isolated from the first intact placental membrane sheet without differentiation of the mesenchymal stem cells that are native to the first intact placental membrane sheet into osteoblasts.
24. The method according to claim 23 further comprising folding the first intact placental membrane sheet.
25. The method according to claim 23 further comprising stacking additional placental membrane sheets on the first intact placental membrane sheet.
26. The method according to claim 23 further comprising, prior to inserting the first intact placental membrane sheet into the void, forming an implant from the first intact placental membrane sheet, the implant having an interior portion that is separated from an exterior surface of the implant by a basement membrane, wherein the mesenchymal stems cells are located in the interior portion.
27. The method according to claim 26 further comprising preventing leakage of the bone marrow into the interior portion by arranging the exterior surface to be between the bone marrow and the interior portion.